Amdocs (NASDAQ:DOX - Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 6.960-7.020 for the period, compared to the consensus estimate of 6.973. The company issued revenue guidance of $4.5 billion-$4.6 billion, compared to the consensus revenue estimate of $4.5 billion. Amdocs also updated its Q4 2025 guidance to 1.790-1.850 EPS.
Analyst Ratings Changes
Several brokerages recently issued reports on DOX. Wall Street Zen upgraded Amdocs from a "hold" rating to a "buy" rating in a report on Sunday. Wolfe Research initiated coverage on Amdocs in a research report on Tuesday, July 8th. They issued an "outperform" rating on the stock. Five research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company has a consensus rating of "Buy" and an average target price of $105.33.
Get Our Latest Stock Report on DOX
Amdocs Stock Performance
Shares of NASDAQ DOX traded down $2.96 during trading on Monday, reaching $86.45. 1,154,551 shares of the stock traded hands, compared to its average volume of 788,117. Amdocs has a 52-week low of $78.61 and a 52-week high of $95.41. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.22 and a quick ratio of 1.16. The company has a 50-day moving average of $90.07 and a 200-day moving average of $88.77. The stock has a market capitalization of $9.76 billion, a P/E ratio of 17.54, a price-to-earnings-growth ratio of 1.64 and a beta of 0.51.
Amdocs (NASDAQ:DOX - Get Free Report) last issued its quarterly earnings results on Wednesday, August 6th. The technology company reported $1.72 EPS for the quarter, beating analysts' consensus estimates of $1.71 by $0.01. Amdocs had a return on equity of 19.66% and a net margin of 11.94%. The firm had revenue of $1.14 billion for the quarter, compared to analysts' expectations of $1.13 billion. During the same quarter in the prior year, the firm earned $1.62 EPS. The business's revenue for the quarter was down 8.4% compared to the same quarter last year. Analysts forecast that Amdocs will post 6.21 EPS for the current fiscal year.
Amdocs Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Tuesday, September 30th will be paid a dividend of $0.527 per share. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date is Tuesday, September 30th. Amdocs's payout ratio is presently 42.80%.
Institutional Trading of Amdocs
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Goldman Sachs Group Inc. raised its stake in shares of Amdocs by 12.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 331,146 shares of the technology company's stock valued at $30,300,000 after purchasing an additional 37,087 shares during the period. Jane Street Group LLC raised its stake in shares of Amdocs by 195.4% during the 1st quarter. Jane Street Group LLC now owns 115,929 shares of the technology company's stock valued at $10,608,000 after purchasing an additional 76,683 shares during the period. Millennium Management LLC raised its stake in shares of Amdocs by 458.3% during the 1st quarter. Millennium Management LLC now owns 67,047 shares of the technology company's stock valued at $6,135,000 after purchasing an additional 55,038 shares during the period. Empowered Funds LLC raised its stake in shares of Amdocs by 12.0% during the 1st quarter. Empowered Funds LLC now owns 15,979 shares of the technology company's stock valued at $1,462,000 after purchasing an additional 1,709 shares during the period. Finally, Amundi increased its stake in Amdocs by 73.0% in the 1st quarter. Amundi now owns 13,778 shares of the technology company's stock worth $1,217,000 after acquiring an additional 5,816 shares during the last quarter. 92.02% of the stock is currently owned by institutional investors.
About Amdocs
(
Get Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Featured Stories
Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access